The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)(((4-chlorophenyl)sulfonyl)imino)methyl)picolinimidamide ID: ALA4089263
PubChem CID: 137644772
Max Phase: Preclinical
Molecular Formula: C28H22Cl2N6O2S
Molecular Weight: 577.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N/C(=N/C(=N\S(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)c1ccccn1
Standard InChI: InChI=1S/C28H22Cl2N6O2S/c29-21-11-9-20(10-12-21)26-24(19-6-2-1-3-7-19)18-36(34-26)28(33-27(31)25-8-4-5-17-32-25)35-39(37,38)23-15-13-22(30)14-16-23/h1-17,24H,18H2,(H2,31,33,35)
Standard InChI Key: URBDEESKRCZDQU-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
5.8276 -7.1855 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0423 -6.3972 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.2523 -6.6055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5784 -3.9315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2584 -4.3847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9008 -3.8795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6165 -3.1106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8010 -3.1465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2904 -5.2013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5993 -5.6373 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0136 -5.5818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8761 -5.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1850 -5.6929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7689 -6.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7979 -7.5947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5203 -7.9751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2124 -7.5390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1775 -6.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4548 -6.3416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2969 -2.5070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6002 -1.7469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0940 -1.1064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2845 -1.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9838 -1.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4919 -2.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0654 -2.4329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8820 -2.4855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3340 -1.8057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9707 -1.0728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1507 -1.0238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7023 -1.7045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7767 -0.5843 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.9361 -7.9185 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.4627 -4.5441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8763 -3.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4636 -3.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6388 -3.1191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2284 -3.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6434 -4.5478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 2 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 2 0
12 13 1 0
11 2 1 0
2 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
8 20 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
7 26 1 0
23 32 1 0
17 33 1 0
12 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 577.50Molecular Weight (Monoisotopic): 576.0902AlogP: 5.34#Rotatable Bonds: 5Polar Surface Area: 113.37Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 3.88CX LogP: 5.52CX LogD: 5.52Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.25Np Likeness Score: -1.01
References 1. Iyer MR, Cinar R, Katz A, Gao M, Erdelyi K, Jourdan T, Coffey NJ, Pacher P, Kunos G.. (2017) Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis., 60 (3): [PMID:28085283 ] [10.1021/acs.jmedchem.6b01504 ]